Hyperlipidemia News and Research

RSS
Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.
Daiichi Sankyo receives marketing approval for Inavir in Japan

Daiichi Sankyo receives marketing approval for Inavir in Japan

Latest achievements in brain research and treatment for mental disorders

Latest achievements in brain research and treatment for mental disorders

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Naringenin from grape fruits initiates increased fatty acid oxidation, inhibits vLDL production

Naringenin from grape fruits initiates increased fatty acid oxidation, inhibits vLDL production

Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN

Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN

Daiichi Sankyo reaches agreement with Apotex to settle Evoxac patent litigation

Daiichi Sankyo reaches agreement with Apotex to settle Evoxac patent litigation

ArQule, Daiichi Sankyo announce decision to advance ARQ 197 into Phase 3 clinical trial for NSCLC

ArQule, Daiichi Sankyo announce decision to advance ARQ 197 into Phase 3 clinical trial for NSCLC

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

AD may lead to increased risk of comorbid conditions, research shows

AD may lead to increased risk of comorbid conditions, research shows

Accumetrics, Daiichi Sankyo, Eli Lilly collaborate to raise awareness about antiplatelet therapy

Accumetrics, Daiichi Sankyo, Eli Lilly collaborate to raise awareness about antiplatelet therapy

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Daiichi Sankyo, Eli Lilly respond to ACCF/AHA clinical alert on FDA's clopidogrel boxed warning

Daiichi Sankyo, Eli Lilly respond to ACCF/AHA clinical alert on FDA's clopidogrel boxed warning

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Gastric bypass surgery can help improve ratio of total cholesterol to HDL cholesterol: Study

Gastric bypass surgery can help improve ratio of total cholesterol to HDL cholesterol: Study

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Idera reports preliminary results from IMO-3100 Phase 1 clinical trial for autoimmune, inflammatory diseases

Idera reports preliminary results from IMO-3100 Phase 1 clinical trial for autoimmune, inflammatory diseases

ArQule, Daiichi Sankyo present positive data from Phase 2 combination ARQ 197 trial for lung cancer at ASCO

ArQule, Daiichi Sankyo present positive data from Phase 2 combination ARQ 197 trial for lung cancer at ASCO

CHD mortality rate in Ontario decreased by 35%: Study

CHD mortality rate in Ontario decreased by 35%: Study